FDA Approved: SYNAGIS — Supplemental Application (Swedish Orphan Biovitrum AB (publ))

View source ↗

Summary

FDA approved a supplemental application for SYNAGIS (palivizumab) submitted by Swedish Orphan Biovitrum AB (publ), resulting in an approved update to the produc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infection

Drugs mentioned

• Synagis (palivizumab)

Snippet

SUPPL AP for SYNAGIS (PALIVIZUMAB)